InvestorsHub Logo
Followers 66
Posts 7541
Boards Moderated 0
Alias Born 03/06/2016

Re: CHM_760 post# 26685

Thursday, 06/20/2019 5:04:07 PM

Thursday, June 20, 2019 5:04:07 PM

Post# of 34626
Thank you for the link!!!

Let’s see if I understand this correctly.

1) PC was not one of top 5 trials we were anticipating results on this year?

2) Something happen with the patients previously enrolled to reopen recruiting?

3) PC now being presented at next month’s AACR? The AACR opens (first thing in the morning) with the plenary presentation. By definition plenary means complete, comprehensive, entire, full, total, whole data (I looked up the definition).
Questions:
Why a follow up poster presentation in the afternoon following the plenary presentation? Too much data to be digested in the 2 hour presentation? Is it to provide a Q&A session that will be recapped on Monday to all investors?

4) Investor conference being held on the next business day following AACR presentations? Is this Marker’s MO?

I suspect the FDA wants to see a few more positive responses in the next six months and if results are duplicated we may see some sort of accelerated approval and thus the need for the result news on cash raise.

I can’t see anything but extremely favorable news coming next month.
July 19th is my late mom’s birthday and it will be fitting to see an after hour PR on what is being presented the next morning.

There are just too many dots pointing to success.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News